Serina Therapeutics Inc SER

US Biotechnology

$2.00 ▼ -1.96% ($-0.04)

🎈 Low Float 🗓️ Earnings Next Week

Open $2.03

Prev Close $2.04

Day Range $2.00 – $2.12

52W Range $1.22 – $7.92

Market Cap $30.00M

Beta 7.72

EPS (TTM) $-1.89

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	2018-11-29
Shares Out.	15,000,000
Website	serinatherapeutics.com/ ↗
Phone	12563279630
Employees	16
Net Income	-$6.9M
Free Cash Flow	-$18.3M
Total Assets	$27.3M
Total Liabilities	$9.7M
Equity	$17.6M

About Serina Therapeutics Inc

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Serina Therapeutics Inc is a publicly traded company under the ticker symbol SER on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.